1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Molecular Diagnostics Market Analysis: By Products (Analyzers, Reagents); By Technology (PCR, INAAT, Hybridization, DNA Sequencing and Next Generation Sequencing, Microarray, Spectral Karyotype Imaging (SKI), Others); By End Users (Hospitals, Clinical Lab

Molecular Diagnostics is a diasnosis technique that utilizes DNA, RNA and proteins to detect specific health condition or diseases. Molecular Diagnostics represents enormous market growth of in-vitro diagnostics and now-a-days routinely used in hospitals, reference labs, and blood banks.

This report gives an in-depth segmentation of the market by products, technology and applications. It also segmented by end user verticals and key geographic regions like Americas, Europe and Asia-pacific. Cost analysis, pricing analysis and the overall competitive landscape of key players are also analyzed in great detail in the report.

Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided.

The prominent players profiled in this report are:
Abbott Diagnostics
Beckman Coulter
Becton
Dickinson & Co
Biomérieux.
The report contains the most detailed and in-depth segmentation of the global Molecular Diagnostics market.

Table Of Contents

Molecular Diagnostics Market Analysis: By Products (Analyzers, Reagents); By Technology (PCR, INAAT, Hybridization, DNA Sequencing and Next Generation Sequencing, Microarray, Spectral Karyotype Imaging (SKI), Others); By End Users (Hospitals, Clinical Lab
1. Molecular Diagnostics Market - Market Overview

2. Executive Summary

3. Molecular Diagnostics Market - Market Landscape

3.1. Market Share Analysis

3.2. Comparative Analysis

3.2.1. Product Benchmarking

3.2.2. End user profiling

3.2.3. Patent Analysis

3.2.4. Top 5 Financials Analysis

4. Molecular Diagnostics Market - Market Forces

4.1. Market Drivers

4.2. Market Constraints

4.3. Market Challenges

4.4. Attractiveness of the Industry

4.4.1. Power of Suppliers

4.4.2. Power of Customers

4.4.3. Threat of New entrants

4.4.4. Threat of Substitution

4.4.5. Degree of Competition

5. Molecular Diagnostics Market - Government Regulations

6. Molecular Diagnostics Market - Strategic Analysis

6.1. Value Chain Analysis

6.2. Pricing Analysis

6.3. Opportunities Analysis

6.4. Product/Market Life Cycle Analysis

7. Molecular Diagnostics Market - By Products

7.1. Analyzers

7.2. Reagents

8. Molecular Diagnostics Market - By Technology

8.1. PCR

8.2. INAAT

8.3. Hybridization

8.4. DNA Sequencing and Next Generation Sequencing

8.5. Microarray

8.6. Spectral Karyotype Imaging (SKI)

8.7. Others

9. Molecular Diagnostics Market - By End Users

9.1. Hospitals

9.2. Clinical Laboratories

9.3. Academics

10. Molecular Diagnostics Market - By Applications

10.1. Infectious Disease

10.1.1. HBV

10.1.2. HCV

10.1.3. HIV

10.1.4. TB

10.1.5. CT/NG

10.1.6. HPV

10.1.7. MRSA

10.1.8. Others

10.2. Oncology

10.2.1. Prostate Cancer

10.2.2. Breast Cancer

10.2.3. Colorectal Cancer

10.2.4. Others

10.3. Genetic Disease Screening

10.4. Blood Screening

10.5. Microbiology

10.6. Others

11. Molecular Diagnostics Market - Geographic Analysis

11.1. Americas

11.2. Europe

11.3. APAC

11.4. ROW

12. Market Entropy

12.1. New Product Launches

12.2. MandAs, Collaborations, JVs and Partnerships

13. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)

13.1. Abbott Diagnostics, Inc.

13.2. Beckman Coulter, Inc.

13.3. Becton, Dickinson and Co.

13.4. Biomerieux

13.5. Cepheid, Inc.

13.6. Gen-Probe, Inc. (Hologic, Inc.)

13.7. Novartis AG

13.8. Qiagen N.V.

13.9. F. Hoffmann-La Roche Ltd.

13.10. Siemens Healthcare

13.11. Myriad Genetics, Inc.

13.12. Danaher Corporation

13.13. Bio-Rad Laboratories, Inc.

13.14. Quest Diagnostics, Inc.

13.15. Thermo Fisher Scientific

13.16. Johnson and Johnson

13.17. Sysmex

13.18. Bayer Healthcare AG

13.19. Alere Inc.

13.20. Leica Biosystems

13.21. Agilient Technologies, Inc


"*Financials would be provided on a best efforts basis for private companies"

14. Appendix

14.1. Abbreviations

14.2. Sources

14.3. Research Methodology

14.4. Bibliography

14.5. Compilation of Expert Insights

14.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Chinese Market for DNA Sequencing

The Chinese Market for DNA Sequencing

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about recent advances and trends in the Chinese sequencing industry and market. - Analyze the Chinese sequencing market by workflow, including sample preparation products, ...

Biobanking: Technologies and Global Markets

Biobanking: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Analyze the role biobanks play in the development of new drugs for specific disease treatments. - Learn about the prevailing market size for certain biobank services available ...

Glycobiology: Global Markets for Diagnostics and Therapeutics

Glycobiology: Global Markets for Diagnostics and Therapeutics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Evaluate new commercial opportunities in the glycobiology diagnostics, therapeutics and research tools market. - Analyze major market participants, including current and future ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.